Cas:387845-23-0 2-(oxan-2-yloxy)cyclopropan-1-amine manufacturer & supplier

We serve Chemical Name:2-(oxan-2-yloxy)cyclopropan-1-amine CAS:387845-23-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(oxan-2-yloxy)cyclopropan-1-amine

Chemical Name:2-(oxan-2-yloxy)cyclopropan-1-amine
CAS.NO:387845-23-0
Synonyms:2-(oxan-2-yloxy)cyclopropan-1-amine
Molecular Formula:C8H15NO2
Molecular Weight:157.21000
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:44.48000
Exact Mass:157.11000
LogP:1.32950

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(oxan-2-yloxy)cyclopropan-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(oxan-2-yloxy)cyclopropan-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(oxan-2-yloxy)cyclopropan-1-amine Use and application,2-(oxan-2-yloxy)cyclopropan-1-amine technical grade,usp/ep/jp grade.


Related News: American Airlines and Delta Air Lines announced more flight cancellations to China on Saturday as coronavirus cases continued to rise. 2-(oxan-2-yloxy)cyclopropan-1-amine manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 2-(oxan-2-yloxy)cyclopropan-1-amine supplier American Airlines and Delta Air Lines announced more flight cancellations to China on Saturday as coronavirus cases continued to rise. 2-(oxan-2-yloxy)cyclopropan-1-amine vendor American Airlines and Delta Air Lines announced more flight cancellations to China on Saturday as coronavirus cases continued to rise. 2-(oxan-2-yloxy)cyclopropan-1-amine factory This is how an API becomes a medicine.